PortfoliosStock ScreensStocksStockXcel

Bliss Gvs Pharma Limited

BLISSGVS | NSE

229.40

INR

13.81

6.41%

BLISSGVS | NSE
Loading StockChartView...

About Bliss Gvs Pharma Limited

Sector

Healthcare

Industry

Drug Manufacturers-Specialty & Generic

Earnings date

31/03/2024

As of date

01/04/2026

Close

229.40

Open

228.00

High

233.80

Low

221.87

Bliss GVS Pharma Limited develops manufactures and markets pharmaceutical formulations in India. It offers pharma products including capsules creams/gels/ointments dry powder for injections and oral suspensions effervescent tablets eye/ear drops injections liquid preparations lotions lozenges nasal solutions oral solids parenterals pessaries sachets soft gelatin capsules suppositories suspensions syrups tablets topical preparations and transdermal patches. The company provides other healthcare products such as balms creams lotions lozenges nasal inhalers over the counter products petroleum jellies powders roll-ons shampoos soaps solutions sprays syrups and vaginal washes. In addition it offers therapeutic products consisting of anti-bacterial anti-dandruff shampoo amino acid preparation iron tonic antitussive appetite stimulant anti-allergic body supplement anti-biotic anti-diabetic anti-diarrheal anti-emetic anti-fungal anti-haemorrhoidal anti-helmintic anti-infective anti-inflammatory anti-malarial anti-microbial anti-migraine anti-oxidant anti-protozoal ear wax solvent anti-pyretic anti-septic anti-spasmodic anti-ulcer and anti-ulcerant; and analgesic oral rehydration antacid anxiolytic appetizer cough syrup erectile dysfunction haematinic hand sanitizer health supplement insecticide laryngitis pharyngitis laxative lubricant mosquito repellant nasal decongestant nutritional supplement moisturizer prickly heat powder skin lightening lotion vaginal contraceptive vaginal hygiene and vitamin supplements as well as soaps. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai India.

View Less

BLISSGVS | NSE

Risk
73.8
Sharpe
1.43
Luna's Score
66/100
Recommendation
Buy

Luna says (BLISSGVS | NSE)

What's Working

Positive Momentum

Strength based on increasing price with high volume

Low Debt to Equity (< 0.25)

Low Debt to Asset (< 0.2)

Value Stock (Price to Book < 3)

Strong Revenue Growth (> 10%)

Strong Sharpe Ratio (> 1.2)

What's not Working

High Short-term Volatility

High 6-Month Volatility (>65%)

Microcap (<300M USD)

High Market Beta (> 0.8)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

Loading RiskMeterView...

10 days

92.0%

1 month

73.8%

3 months

67.8%

6 months

67.8%

Returns

Loading ReturnMeterView...

Fundamental Ratios

PE

17.04

Fwd. PE

-

Price to book

1.51

Debt to equity

0.10

Debt to assets

0.08

Ent. to EBITDA

8.99

Ent. to rev.

1.80

PEG

-

Other Fundamentals

EBITDA

1.59B

MarketCap

24.16B

MarketCap(USD)

259.23M

Div. yield

0.38

Op. margin

14.97

Erngs. growth

39.90

Rev. growth

15.10

Ret. on equity

8.50

Short ratio

-

Short perc.

-

Market Sentiment (SMA and Price signals)

Short-term: Bullish (SMA10D > SMA1M)

Intermediate-term: Bullish (SMA1M > SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Loading MovingAverageView...

Range10D

40.73

Range1M

40.73

Range3M

91.64

Volumes: Market Activity

Volume Averages

Loading VolumeAverageView...

Rel. volume

1.62

Price X volume

691.94M

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Orchid Pharma LimitedORCHPHARMADrug Manufacturers-Specialty & Generic519.326.44B7.64%59.9211.56%
Dishman Carbogen Amcis LimitedDCALBiotechnology146.1422.91B12.44%n/a41.09%
Unichem Laboratories LimitedUNICHEMLABDrug Manufacturers-Specialty & Generic298.221.07B1.62%n/a10.48%
Morepen Laboratories LimitedMOREPENLABDrug Manufacturers-Specialty & Generic37.220.55B10.45%37.533.42%
Panacea Biotec LimitedPANACEABIOBiotechnology325.320.30B9.88%n/a2.49%
SOLARASOLARADrug Manufacturers-Specialty & Generic459.119.89B7.88%n/a107.90%
Hikal LimitedHIKALDrug Manufacturers-Specialty & Generic159.9619.72B8.76%69.0368.84%
Alembic LimitedALEMBICLTDDrug Manufacturers-Specialty & Generic76.4919.71B7.88%12.290.42%
Indoco Remedies LimitedINDOCODrug Manufacturers-Specialty & Generic187.0817.24B14.07%42.2260.54%
Windlas Biotech LimitedWINDLASDrug Manufacturers-Specialty & Generic767.6516.10B4.19%35.850.81%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
"SAI SILKS (KALAMANDIR) LIMITED "KALAMANDIRApparel Retail101.3414.93B12.25%28.8343.67%
Signpost India LimitedSIGNPOSTAdvertising Agencies231.1113.55B4.36%30.5480.30%
V2 Retail LimitedV2RETAILApparel Retail189.426.76B0.17%120.49191.28%
Bhagyanagar India LtdBHAGYANGRCopper151.064.88B9.69%36.3652.08%
Madhav Copper LimitedMCLCopper57.491.59B4.99%82.2232.14%
Cubex Tubings LimitedCUBEXTUBCopper83.81.22B13.34%35.8521.78%
Touchwood Entertainment LimitedTOUCHWOODAdvertising Agencies65.89734.59M4.50%50.064.88%
Sagardeep Alloys LimitedSAGARDEEPCopper22.89397.37M3.95%58.6243.14%
Heads UP Ventures LimitedHEADSUPApparel Retail6.92151.62M14.38%n/a0.00%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA8.9924.85Cheaper
Ent. to Revenue1.8011.40Cheaper
PE Ratio17.0451.36Cheaper
Price to Book1.516.83Cheaper
Dividend Yield0.380.52Poor
Std. Deviation (3M)67.8042.17Riskier
Debt to Equity0.100.35Cheaper
Debt to Assets0.080.17Cheaper
Market Cap24.16B290.82BEmerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007